Pharmacokinetics and Nephrotoxicity of Polymyxin MRX-8 in Rats: A Novel Agent against Resistant Gram-Negative Bacteria
MRX-8 is a novel polymyxin for carbapenem-resistant Gram-negative infections that has been recently evaluated in Phase I clinical trials. Herein, its pharmacokinetics (PK) and nephrotoxicity in rats are reported for the first time. This study aimed at pre-clinical PK and safety assessments. An LC-MS...
Saved in:
Main Authors: | Xingyi Qu (Author), Chenxue Guo (Author), Shaojun Liu (Author), Xin Li (Author), Lin Xi (Author), Xiaofen Liu (Author), Jing Zhang (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetic/Pharmacodynamic Based Breakpoints of Polymyxin B for Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Pathogens
by: Xingchen Bian, et al.
Published: (2022) -
Polymyxin B-Associated Nephrotoxicity and Its Predictors: A Retrospective Study in Carbapenem-Resistant Gram-Negative Bacterial Infections
by: Xiao-Li Wu, et al.
Published: (2022) -
Comparative pharmacokinetics of polymyxin B in critically ill elderly patients with extensively drug-resistant gram-negative bacteria infections
by: Juan Zeng, et al.
Published: (2024) -
Population Pharmacokinetics of Polymyxin B in Obese Patients for Resistant Gram-Negative Infections
by: Peile Wang, et al.
Published: (2021) -
Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Carbapenem-Resistant Gram-Negative Bacterial Infections Among Chinese Children
by: Xuedong Jia, et al.
Published: (2022)